These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29205157)

  • 21. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
    Kandzari DE; Mauri L; Koolen JJ; Massaro JM; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    Lancet; 2017 Oct; 390(10105):1843-1852. PubMed ID: 28851504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrathin, Biodegradable-Polymer Sirolimus-Eluting Stent vs Thin, Durable-Polymer Everolimus-Eluting Stent.
    Nakamura M; Kadota K; Nakagawa Y; Tanabe K; Ito Y; Amano T; Maekawa Y; Takahashi A; Shiode N; Otsuka Y; Kawasaki T; Hikichi Y; Shite J; Kozuma K; Iijima R; Murakami Y;
    JACC Cardiovasc Interv; 2022 Jul; 15(13):1324-1334. PubMed ID: 35798475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents and Thin, Durable-Polymer Everolimus-Eluting Stents in Calcified or Small Vessel Lesions.
    Dan K; Garcia-Garcia HM; Kolm P; Windecker S; Saito S; Kandzari DE; Waksman R
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009189. PubMed ID: 32895004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy.
    Mankerious N; Hemetsberger R; Traboulsi H; Toelg R; Abdel-Wahab M; Richardt G; Allali A
    Clin Res Cardiol; 2021 Oct; 110(10):1574-1585. PubMed ID: 33861369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    von Birgelen C; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Gin RMTJ; Somi S; van Houwelingen KG; Stoel MG; de Man FHAF; Louwerenburg JHW; Hartmann M; Zocca P; Linssen GCM; van der Palen J; Doggen CJM; Löwik MM
    Lancet; 2016 Nov; 388(10060):2607-2617. PubMed ID: 27806902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable polymer-coated thin strut sirolimus- -eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population.
    Gasior P; Gierlotka M; Szczurek-Katanski K; Osuch M; Roleder M; Hawranek M; Wojakowski W; Polonski L
    Cardiol J; 2021; 28(2):235-243. PubMed ID: 31909473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.
    Cassese S; Ndrepepa G; Byrne RA; Kufner S; Lahmann AL; Mankerious N; Xhepa E; Laugwitz KL; Schunkert H; Fusaro M; Kastrati A; Joner M
    EuroIntervention; 2018 Jun; 14(2):224-231. PubMed ID: 29537375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial.
    Iglesias JF; Heg D; Roffi M; Degrauwe S; Tüller D; Muller O; Brinkert M; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T
    Cardiovasc Revasc Med; 2022 Jan; 34():3-10. PubMed ID: 33653633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.
    Gao RL; Xu B; Lansky AJ; Yang YJ; Ma CS; Han YL; Chen SL; Li H; Zhang RY; Fu GS; Yuan ZY; Jiang H; Huo Y; Li W; Zhang YJ; Leon MB;
    EuroIntervention; 2013 May; 9(1):75-83. PubMed ID: 23685298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.
    Lansky AJ; Xu B; Baumbach A; Kelbæk H; van Royen N; Zheng M; Knaapen P; Slagboom T; Johnson TW; Vlachojannis GJ; Arkenbout KE; Holmvang L; Janssens L; Brugaletta S; Naber CK; Schmitz T; Anderson R; Rittger H; Berti S; Barbato E; Toth GG; Maillard L; Valina CM; Buszman PE; Thiele H; Schächinger V; Wijns W
    EuroIntervention; 2023 Dec; 19(10):e844-e855. PubMed ID: 37860860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
    Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
    Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial.
    Modolo R; Chichareon P; Kogame N; Asano T; Chang CC; de Winter RJ; Kaul U; Zaman A; Spitzer E; Takahashi K; Katagiri Y; Soliman OII; van Es GA; Morel MA; Onuma Y; Serruys PW
    EuroIntervention; 2019 Jul; 15(4):e362-e369. PubMed ID: 30066672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.
    Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ
    JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angioscopic Comparison of Early- and Mid-Term Vascular Responses Following Treatment of ST-Elevation Acute Myocardial Infarction With Biodegradable vs. Durable Polymer Everolimus-Eluting Stents　- A Prespecified Subanalysis of the MECHANISM AMI RCT.
    Nakatani S; Sotomi Y; Suzuki S; Kobayashi T; Hamanaka Y; Omatsu T; Ishida M; Kakizaki S; Otake H; Morino Y; Higuchi Y;
    Circ J; 2023 Apr; 87(5):619-628. PubMed ID: 36418112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.
    Iglesias JF; Roffi M; Degrauwe S; Secco GG; Aminian A; Windecker S; Pilgrim T
    Expert Rev Med Devices; 2017 Oct; 14(10):773-788. PubMed ID: 28889769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus.
    Waksman R; Shlofmitz E; Windecker S; Koolen JJ; Saito S; Kandzari D; Kolm P; Lipinski MJ; Torguson R
    Am J Cardiol; 2019 Oct; 124(7):1020-1026. PubMed ID: 31353004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of MECHANISM of early and late vascular responses following treatment of ST-elevation acute myocardial infarction with two different everolimus-eluting stents: a randomized controlled trial of biodegradable versus durable polymer stents.
    Otake H; Ishida M; Nakano S; Higuchi Y; Hibi K; Kuriyama N; Iwasaki M; Kataoka T; Kubo T; Tsujita K; Ashikaga T; Shinke T; Itoh T; Kimura T; Morino Y;
    Cardiovasc Interv Ther; 2023 Jan; 38(1):75-85. PubMed ID: 35896895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: 5-Year Outcomes of the Randomized BIOFLOW-II Trial.
    Lefèvre T; Haude M; Neumann FJ; Stangl K; Skurk C; Slagboom T; Sabaté M; Goicolea J; Barragan P; Cook S; Macia JC; Windecker S
    JACC Cardiovasc Interv; 2018 May; 11(10):995-1002. PubMed ID: 29798778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.
    Gasior P; Gierlotka M; Szczurek-Katanski K; Osuch M; Gnot R; Hawranek M; Gasior M; Polonski L
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):E362-E368. PubMed ID: 30298545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.